Skip to content

Serotonin research published in 2015

Page 2 of 2: studies 21 to 22 of 22, newest first. Back to the serotonin overview

Studies

Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.

Neuropharmacology February 1, 2015 Xi-Ling Jiang, Hong-Wu Shen, Ai-Ming Yu 26 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and harmaline are serotonin (5-HT) analogs often abused together, which alters thermoregulation that may indicate the severity of serotonin toxicity. Our recent studies have revealed that co-administration of monoamine oxidase inhibitor harmaline leads to greater and prolonged exposure to 5-HT agonist 5-MeO-DMT that might be influenced by cytochrome...

DOI: 10.1016/j.neuropharm.2014.10.013 (opens in new tab) Full text (opens in new tab) Thermoregulation Temperature control Thermal regulation Drug interaction +13

Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling

Swiss Medical Weekly January 11, 2015 Matthias E. Liechti 188 citations

Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as phenethylamines, amphetamines, synthetic cathinones, piperazines, pipradrols/piperidines, aminoindanes benzofurans, and tryptamines....

DOI: 10.4414/smw.2015.14043 (opens in new tab) Serotonin Pharmacology Designer drug Monoamine neurotransmitter +1